Xortx Therapeutics Inc (XRTX)

$0.40 -0.05 (-10.89%)
Market Cap 2.79M
Revenue (ttm) 0.00
Net Income (ttm) -2.66M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 62,400
Avg Vol 164,142
Day's Range N/A - N/A
Shares Out 6.96M
Stochastic %K 30%
Beta 0.51
Analysts Strong Buy
Price Target $14.00

Company Profile

XORTX Therapeutics Inc., a late-stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat hyperuricemia related diseases in Canada. It develops XRx-026, which is in Phase III for the treatment of gout; XRx-008, which is in Phase II for the treatment of autosomal dominant polycystic kidney disease; XRx-101, which is in Phase II for the treatment of acute kidney injury associated with respiratory virus infection, including sepsis and coronavirus;...

Industry: Biotechnology
Sector: Healthcare
Phone: 403-455-7727
Address:
3710 - 33rd Street NW, Calgary, Canada
honestrick
honestrick Mar. 11 at 8:27 PM
$SXTP Will $XRTX be next ? GLTA .
0 · Reply
honestrick
honestrick Mar. 9 at 4:00 PM
$XRTX Did anyone get the package and vote yet on the annual meeting proposals yet ?
0 · Reply
VintageVibes
VintageVibes Mar. 9 at 5:34 AM
$XRTX Looks like a good buy zone?
1 · Reply
A_I_Bot
A_I_Bot Mar. 5 at 7:13 PM
$XRTX "Compliance Requirement: To regain compliance, the company's common stock must close at or above $1.00 for a minimum of 10 consecutive business days before the April 13, 2026 deadline"
0 · Reply
warm_it_up
warm_it_up Mar. 4 at 12:48 PM
$XRTX you know why I like this ticker? You never have to worry about it. It's perpetually red, so there's never a need to check it!
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Mar. 4 at 2:11 AM
$XRTX RSI: 42.44, MACD: -0.0311 Vol: 0.03, MA20: 0.42, MA50: 0.51 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
honestrick
honestrick Feb. 27 at 3:54 PM
$DRUG $NVDA Just sell 50 shares and buy $XRTX .Help a guy out ,You never know what they will announce at there webcast in March .
1 · Reply
honestrick
honestrick Feb. 27 at 3:14 PM
$NVDA $XRTX markets red to green ? GLTA
0 · Reply
aafetygod
aafetygod Feb. 27 at 2:27 PM
$XRTX Even if it shoots up right now, it probably won't go higher than 0.5... Personally, I hope this stock drops to the 0.15-0.2 range.
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 23 at 3:52 PM
$XRTX Current Stock Price: $0.40
0 · Reply
Latest News on XRTX
XORTX Reports that Independent Proxy Advisory Firms Recommend XORTX Shareholders Vote “For” the Share Consolidation

Fri, 13 Mar 2026 07:00:00 -0400 - 3 days ago

XORTX Reports that Independent Proxy Advisory Firms Recommend XORTX Shareholders Vote “For” the Share Consolidation

XORTX Therapeutics (XRTX) Announces Key Shareholder Meeting Agenda

2026-03-05T12:33:09.000Z - 11 days ago

XORTX Therapeutics (XRTX) Announces Key Shareholder Meeting Agenda

Why Align Technology Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket

2026-02-05T09:34:03.000Z - 5 weeks ago

Why Align Technology Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket

XORTX Extends Closing Of Renal Anti-Fibrotic Therapeutic Program Acquisition; Stock Soars

2026-02-05T07:10:06.000Z - 5 weeks ago

XORTX Extends Closing Of Renal Anti-Fibrotic Therapeutic Program Acquisition; Stock Soars

XORTX Announces Pricing of US$1.1 Million Registered Direct Offering

Tue, 21 Oct 2025 08:00:00 -0400 - 5 months ago

XORTX Announces Pricing of US$1.1 Million Registered Direct Offering

XORTX Therapeutics (XRTX) Secures Nasdaq Extension to Meet Bid Price Rule

2025-10-21T06:55:29.000Z - 5 months ago

XORTX Therapeutics (XRTX) Secures Nasdaq Extension to Meet Bid Price Rule

XORTX Issues Correction Notice and XORTX Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Deficiency

Mon, 20 Oct 2025 20:34:00 -0400 - 5 months ago

XORTX Issues Correction Notice and XORTX Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Deficiency

XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

Mon, 20 Oct 2025 18:45:00 -0400 - 5 months ago

XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

XORTX (XRTX) Acquires Renal Therapeutic Program from Vectus

2025-10-17T12:35:39.000Z - 5 months ago

XORTX (XRTX) Acquires Renal Therapeutic Program from Vectus

XORTX Announces Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems

Fri, 17 Oct 2025 07:00:00 -0400 - 5 months ago

XORTX Announces Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems

XORTX Therapeutics goes ‘toe to toe’ with gout by accelerating its lead drug program targeting this complex disease

2025-09-09T13:01:00.000Z - 6 months ago

XORTX Therapeutics goes ‘toe to toe’ with gout by accelerating its lead drug program targeting this complex disease

XORTX Initiates IND Preparation for XORLO™ in Gout Program

Wed, 03 Sep 2025 07:00:00 -0400 - 6 months ago

XORTX Initiates IND Preparation for XORLO™ in Gout Program

XORTX Completes USD $114,500 Private Placement

Fri, 08 Aug 2025 19:54:00 -0400 - 7 months ago

XORTX Completes USD $114,500 Private Placement

XORTX Completes Non-Brokered Private Placement of Units

Tue, 22 Jul 2025 19:59:00 -0400 - 8 months ago

XORTX Completes Non-Brokered Private Placement of Units

XORTX Announces USD $925,000 Private Placement

Thu, 26 Jun 2025 07:00:00 -0400 - 9 months ago

XORTX Announces USD $925,000 Private Placement

XORTX Announces USD $3 Million Offering

Mon, 19 May 2025 07:00:00 -0400 - 10 months ago

XORTX Announces USD $3 Million Offering

XORTX Therapeutics (XRTX) Faces Nasdaq Compliance Challenge

2025-04-18T07:55:25.000Z - 11 months ago

XORTX Therapeutics (XRTX) Faces Nasdaq Compliance Challenge

XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

Thu, 17 Apr 2025 19:45:00 -0400 - 11 months ago

XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

ARMISTICE CAPITAL, LLC Acquires Shares in XORTX Therapeutics Inc

2025-02-15T11:02:46.000Z - 1 year ago

ARMISTICE CAPITAL, LLC Acquires Shares in XORTX Therapeutics Inc

XORTX Announces Change of Auditor

Fri, 17 Jan 2025 17:00:00 -0500 - 1 year ago

XORTX Announces Change of Auditor

IRW-News: XORTX Therapeutics Inc.: XORTX kündigt Präsentation auf dem Rare and Genetic Disease Summit an

2024-12-13T07:01:58.000Z - 1 year ago

IRW-News: XORTX Therapeutics Inc.: XORTX kündigt Präsentation auf dem Rare and Genetic Disease Summit an

XORTX Announces Presentation at the Rare and Genetic Disease Summit

Thu, 12 Dec 2024 09:17:00 -0500 - 1 year ago

XORTX Announces Presentation at the Rare and Genetic Disease Summit

XORTX Announces Closing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement

Fri, 18 Oct 2024 16:00:00 -0400 - 1 year ago

XORTX Announces Closing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement

XORTX Initiates Precision Medicine Program

Wed, 09 Oct 2024 05:00:00 -0400 - 1 year ago

XORTX Initiates Precision Medicine Program

XORTX Announces Results of Annual and Special Meeting of Shareholders

Fri, 13 Sep 2024 07:00:00 -0400 - 1 year ago

XORTX Announces Results of Annual and Special Meeting of Shareholders

XORTX Announces Re-filing of YE 2023 and Q2 2024 MD&A

Thu, 12 Sep 2024 17:30:00 -0400 - 1 year ago

XORTX Announces Re-filing of YE 2023 and Q2 2024 MD&A

XORTX Reminds Shareholders of Voting Deadline for Upcoming Annual and Special Meeting of Shareholders

Fri, 06 Sep 2024 17:30:00 -0400 - 1 year ago

XORTX Reminds Shareholders of Voting Deadline for Upcoming Annual and Special Meeting of Shareholders

Independent Proxy Advisory Firm ISS Recommends XORTX Shareholders Vote FOR ALL Proposed Items at the Upcoming Annual and Special Meeting of Shareholders

Tue, 03 Sep 2024 12:30:00 -0400 - 1 year ago

Independent Proxy Advisory Firm ISS Recommends XORTX Shareholders Vote FOR ALL Proposed Items at the Upcoming Annual and Special Meeting of Shareholders

XORTX Announces Filing and Mailing of the Meeting Documents in Connection with the Annual and Special Meeting of Shareholders

Fri, 23 Aug 2024 07:00:00 -0400 - 1 year ago

XORTX Announces Filing and Mailing of the Meeting Documents in Connection with the Annual and Special Meeting of Shareholders

XORTX Announces Presentation at American Society of Nephrology – Kidney Week 2024

Tue, 20 Aug 2024 07:00:00 -0400 - 1 year ago

XORTX Announces Presentation at American Society of Nephrology – Kidney Week 2024

XORTX Reprices Balance of Warrants Issued in Connection with October 2021 US IPO

Fri, 17 May 2024 07:00:00 -0400 - 1 year ago

XORTX Reprices Balance of Warrants Issued in Connection with October 2021 US IPO

XORTX Reprices Warrants Issued in Connection with Previous Private Placements

Tue, 30 Apr 2024 13:54:00 -0400 - 2 years ago

XORTX Reprices Warrants Issued in Connection with Previous Private Placements

XORTX Announces Publication of Key Research in ADPKD

Mon, 22 Apr 2024 07:00:00 -0400 - 2 years ago

XORTX Announces Publication of Key Research in ADPKD

XORTX Welcomes New Member to the Board of Directors

Mon, 08 Apr 2024 07:30:00 -0400 - 2 years ago

XORTX Welcomes New Member to the Board of Directors

XORTX Announces New Clinical Advisory Board Member

Wed, 27 Mar 2024 05:00:00 -0400 - 2 years ago

XORTX Announces New Clinical Advisory Board Member

XORTX Highlights Achievements of 2023 and Preparation for Registration Clinical Trial

Tue, 19 Mar 2024 05:00:00 -0400 - 2 years ago

XORTX Highlights Achievements of 2023 and Preparation for Registration Clinical Trial

XORTX Finalizes $2.7 Million Prospectus Supplement and Concurrent Private Placement for the Offering of Units

Mon, 04 Mar 2024 07:00:00 -0500 - 2 years ago

XORTX Finalizes $2.7 Million Prospectus Supplement and Concurrent Private Placement for the Offering of Units

XORTX Files an Amended and Restated Prospectus Supplement for the Offering of Units

Thu, 01 Feb 2024 20:46:00 -0500 - 2 years ago

XORTX Files an Amended and Restated Prospectus Supplement for the Offering of Units

XORTX Announces $2 Million Public Offering

Mon, 15 Jan 2024 07:00:00 -0500 - 2 years ago

XORTX Announces $2 Million Public Offering

XORTX Submits a New Patent for the Treatment of Chronic Kidney Disease

Wed, 03 Jan 2024 07:00:00 -0500 - 2 years ago

XORTX Submits a New Patent for the Treatment of Chronic Kidney Disease

XORTX Announces US ATM Offering

Thu, 30 Nov 2023 07:30:00 -0500 - 2 years ago

XORTX Announces US ATM Offering

XORTX Meets Nasdaq Continued Listing Requirements

Wed, 29 Nov 2023 07:00:00 -0500 - 2 years ago

XORTX Meets Nasdaq Continued Listing Requirements

XORTX Clarifies Timing for Share Consolidation

Fri, 10 Nov 2023 07:00:00 -0500 - 2 years ago

XORTX Clarifies Timing for Share Consolidation

XORTX Announces Share Consolidation

Wed, 08 Nov 2023 17:00:00 -0500 - 2 years ago

XORTX Announces Share Consolidation

XORTX Announces Results of Special Meeting of Shareholders

Fri, 27 Oct 2023 17:30:00 -0400 - 2 years ago

XORTX Announces Results of Special Meeting of Shareholders

XORTX Announces Date for Rescheduled Special Meeting of Shareholders

Oct 25, 2023, 5:00 PM EDT - 2 years ago

XORTX Announces Date for Rescheduled Special Meeting of Shareholders

XORTX Announces Rescheduling of Special Meeting of Shareholders

Oct 25, 2023, 7:00 AM EDT - 2 years ago

XORTX Announces Rescheduling of Special Meeting of Shareholders

XORTX Reports that Independent Proxy Firm, ISS, Recommends Shareholders Vote for the Share Consolidation Resolution

Oct 12, 2023, 7:00 AM EDT - 2 years ago

XORTX Reports that Independent Proxy Firm, ISS, Recommends Shareholders Vote for the Share Consolidation Resolution

XORTX Calls Special Meeting of Shareholders

Oct 4, 2023, 7:00 AM EDT - 2 years ago

XORTX Calls Special Meeting of Shareholders

XORTX Submits Orphan Drug Designation Application to the European Medicines Agency (EMA) to Treat Progressive Kidney Disease

Aug 29, 2023, 7:00 AM EDT - 2 years ago

XORTX Submits Orphan Drug Designation Application to the European Medicines Agency (EMA) to Treat Progressive Kidney Disease

XORTX Appoints Chief Financial Officer

Aug 4, 2023, 5:00 PM EDT - 2 years ago

XORTX Appoints Chief Financial Officer

XORTX Reminds Shareholders to Vote ahead of the Proxy Voting Deadline for the Company's Upcoming Annual and Special Meeting of Shareholders

Jun 23, 2023, 8:51 PM EDT - 2 years ago

XORTX Reminds Shareholders to Vote ahead of the Proxy Voting Deadline for the Company's Upcoming Annual and Special Meeting of Shareholders

XORTX Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Deficiency

May 24, 2023, 7:00 AM EDT - 3 years ago

XORTX Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Deficiency

XORTX Announces Receipt of FDA Orphan Drug Designation to Treat Autosomal Dominant Kidney Disease

Apr 21, 2023, 7:00 AM EDT - 3 years ago

XORTX Announces Receipt of FDA Orphan Drug Designation to Treat Autosomal Dominant Kidney Disease

XORTX Announces Submission of Orphan Drug Designation Request for XRx-008 Program to Treat Autosomal Dominant Kidney Disease

Feb 1, 2023, 7:00 AM EST - 3 years ago

XORTX Announces Submission of Orphan Drug Designation Request for XRx-008 Program to Treat Autosomal Dominant Kidney Disease

XORTX Announces Positive Topline Results from XRX-OXY-101 Clinical Trial

Jan 19, 2023, 7:00 AM EST - 3 years ago

XORTX Announces Positive Topline Results from XRX-OXY-101 Clinical Trial

XORTX Announces New Proof of Concept Data in Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Dec 8, 2022, 7:00 AM EST - 3 years ago

XORTX Announces New Proof of Concept Data in Autosomal Dominant Polycystic Kidney Disease (ADPKD)

XORTX Announces Completion of Screening and Enrollment in Bridging Pharmacokinetics Study

Nov 28, 2022, 7:00 AM EST - 3 years ago

XORTX Announces Completion of Screening and Enrollment in Bridging Pharmacokinetics Study

XORTX Therapeutics Appoints Stacy Evans, M.D., MBA as Chief Business Officer

Nov 16, 2022, 7:00 AM EST - 3 years ago

XORTX Therapeutics Appoints Stacy Evans, M.D., MBA as Chief Business Officer

honestrick
honestrick Mar. 11 at 8:27 PM
$SXTP Will $XRTX be next ? GLTA .
0 · Reply
honestrick
honestrick Mar. 9 at 4:00 PM
$XRTX Did anyone get the package and vote yet on the annual meeting proposals yet ?
0 · Reply
VintageVibes
VintageVibes Mar. 9 at 5:34 AM
$XRTX Looks like a good buy zone?
1 · Reply
A_I_Bot
A_I_Bot Mar. 5 at 7:13 PM
$XRTX "Compliance Requirement: To regain compliance, the company's common stock must close at or above $1.00 for a minimum of 10 consecutive business days before the April 13, 2026 deadline"
0 · Reply
warm_it_up
warm_it_up Mar. 4 at 12:48 PM
$XRTX you know why I like this ticker? You never have to worry about it. It's perpetually red, so there's never a need to check it!
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Mar. 4 at 2:11 AM
$XRTX RSI: 42.44, MACD: -0.0311 Vol: 0.03, MA20: 0.42, MA50: 0.51 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
honestrick
honestrick Feb. 27 at 3:54 PM
$DRUG $NVDA Just sell 50 shares and buy $XRTX .Help a guy out ,You never know what they will announce at there webcast in March .
1 · Reply
honestrick
honestrick Feb. 27 at 3:14 PM
$NVDA $XRTX markets red to green ? GLTA
0 · Reply
aafetygod
aafetygod Feb. 27 at 2:27 PM
$XRTX Even if it shoots up right now, it probably won't go higher than 0.5... Personally, I hope this stock drops to the 0.15-0.2 range.
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 23 at 3:52 PM
$XRTX Current Stock Price: $0.40
0 · Reply
aafetygod
aafetygod Feb. 21 at 4:13 AM
$XRTX 0.1-0.2? 0.1, 0.2->0.5?
0 · Reply
honestrick
honestrick Feb. 10 at 7:49 PM
$XRTX Volume coming in heavy for this stock ,any suggestions? $NVDA $DRUG $AAPL
0 · Reply
honestrick
honestrick Feb. 10 at 7:35 PM
$XRTX Why the action?
0 · Reply
SignalStrategist
SignalStrategist Feb. 9 at 12:42 PM
$XRTX is a radiopharmaceutical or radiotherapy company; targeted radiation therapy is a promising but complex field requiring specialized infrastructure.
0 · Reply
Hockey99
Hockey99 Feb. 9 at 3:27 AM
$TRON $TIRX $ROLR $XRTX let’s go big day tomorrow
0 · Reply
REXOM
REXOM Feb. 8 at 6:09 PM
My TOP calls for LAST WEEK ( part 2 ) were : 1- $WTO 0.85 - 1.19 2- $XRTX 0.49 - 0.71 3- $TLIH 0.41 - 0.67 4- $EDHL 0.21 - 0.31 Follow me from my FREE DISCORD. link is under my bio.
0 · Reply
spikespants
spikespants Feb. 6 at 8:58 PM
$XRTX everything in my portfolio is green except for this turd. Down another 0.8%
2 · Reply
Drugtrade
Drugtrade Feb. 6 at 2:55 PM
$XRTX does this ever go up during market hours or does it invariably pump during extended hours only?
2 · Reply
LookaLike
LookaLike Feb. 6 at 8:03 AM
$XRTX posted this yesterday when it started green.
0 · Reply
warm_it_up
warm_it_up Feb. 6 at 12:06 AM
$XRTX today might be my biggest down day since I've been trading. I was busy and missed this stupid f-ing drop after hours. Just like that last time they had news and tanked after hours. It's gotta be gross manipulation. Could it be an offering we don't know about?
0 · Reply
Joshimi
Joshimi Feb. 5 at 9:39 PM
$XRTX ok, now I am intrigued
2 · Reply
Hockey99
Hockey99 Feb. 5 at 9:39 PM
$XRTX wow
1 · Reply